Among the predicted target proteins, AKT1 and TNFα are potentially the core targets of Aloe vera for NASH treatment, while c-Jun and p53 may also contribute to the anti-NASH features. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatohepatitis.